The beneficial effects of Ganoderma lucidum on cardiovascular and metabolic disease risk

Sze Wa Chan, Brian Tomlinson, Paul Chan, Christopher Wai Kei Lam

Research output: Contribution to journalReview articlepeer-review

28 Citations (Scopus)

Abstract

Context: Various herbal medicines are thought to be useful in the management of cardiometabolic disease and its risk factors. Ganoderma lucidum (Curtis) P. Karst. (Ganodermataceae), also known as Lingzhi, has received considerable attention for various indications, including some related to the prevention and treatment of cardiovascular and metabolic disease by ameliorating major cardiovascular risk factors. Objective: This review focuses on the major studies of the whole plant, plant extract, and specific active compounds isolated from G. lucidum in relation to the main risk factors for cardiometabolic disease. Methods: References from major databases including PubMed, Web of Science, and Google Scholar were compiled. The search terms used were Ganoderma lucidum, Lingzhi, Reishi, cardiovascular, hypoglycaemic, diabetes, dyslipidaemia, antihypertensive, and anti-inflammatory. Results: A number of in vitro studies and in vivo animal models have found that G. lucidum possesses antioxidative, antihypertensive, hypoglycaemic, lipid-lowering, and anti-inflammatory properties, but the health benefits in clinical trials are inconsistent. Among these potential health benefits, the most compelling evidence thus far is its hypoglycaemic effects in patients with type 2 diabetes or hyperglycaemia. Conclusions: The inconsistent evidence about the potential health benefits of G. lucidum is possibly because of the use of different Ganoderma formulations and different study populations. Further large controlled clinical studies are therefore needed to clarify the potential benefits of G. lucidum preparations standardised by known active components in the prevention and treatment of cardiometabolic disease.

Original languageEnglish
Pages (from-to)1161-1171
Number of pages11
JournalPharmaceutical Biology
Volume59
Issue number1
DOIs
Publication statusPublished - 2021

Keywords

  • Antihypertensive
  • antioxidant
  • dyslipidaemia
  • hypoglycaemic
  • Lingzhi
  • Reishi

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Drug Discovery
  • Complementary and alternative medicine

Fingerprint

Dive into the research topics of 'The beneficial effects of Ganoderma lucidum on cardiovascular and metabolic disease risk'. Together they form a unique fingerprint.

Cite this